Acidum Benzoicum-Injeel Liq (12d,30d,200d/1.1ml) 12 D / 1.1 mL Liquid is a Health Canada–registered human drug (DIN 02075903) held by Biologische Heilmittel Heel GmbH, containing Benzoic Acid. Health Canada lists its status as Cancelled Post Market (status date 05 Mar 1997). Nexara Health has matched 7 registrations of Benzoic Acid across 3 other regulated markets.
Health Canada registration
| DIN | 02075903 |
|---|---|
| Brand name | Acidum Benzoicum-Injeel Liq (12d,30d,200d/1.1ml) |
| Active ingredient | Benzoic Acid |
| Strength | 12 D / 1.1 mL |
| Dosage form | Liquid |
| Route | Oral |
| Company | Biologische Heilmittel Heel GmbH |
| Status | Cancelled Post Market — 05 Mar 1997 |
| Class | Human |
| ATC | |
| AHFS | 88:29.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Benzoic Acid registered in other markets
7 registrations of the same molecule in 3 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Australia | Benzoic Acid | — | EP | PBS | ||
| Taiwan | Benzoic Acid | Eli. Lilly & Co. | （粉） | 已註銷 | TFDA | |
| Taiwan | Benzoic Acid Ch.p.ii "K.y." | 洸洋化學製藥股份有限公司 | （粉） | 已註銷 | TFDA | |
| United States | Benzoic Acid | Apothecon Pharmaceuticals Pvt Ltd | Powder | FDA NDC | ||
| United States | Benzoicum acidum | Boiron | Pellet | listed | FDA NDC | |
| United States | Benzoicum acidum | Boiron | Pellet | listed | FDA NDC | |
| United States | Benzoicum Acidum | Boiron | Pellet | listed | FDA NDC |
See every manufacturer of Benzoic Acid worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Acidum Benzoicum-Injeel Liq (12d,30d,200d/1.1ml) (DIN 02075903) marketed in Canada?
No. Health Canada lists DIN 02075903 as Cancelled Post Market as of 05 Mar 1997.
Who holds the Canadian licence for this product?
Biologische Heilmittel Heel GmbH is the company of record in the Health Canada Drug Product Database.
Is Benzoic Acid registered outside Canada?
Yes — Nexara Health has matched 7 registrations in 3 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02075903, status date 1997-03-05; national medicine registries: FDA NDC, PBS, TFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02075903, status date 1997-03-05; national medicine registries: FDA NDC, PBS, TFDA.
Health Canada Drug Product Database (DPD), DIN 02075903, status date 1997-03-05; national medicine registries: FDA NDC, PBS, TFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.